111 related articles for article (PubMed ID: 7684259)
1. The need for second-generation antihepatitis C virus testing in uremic patients on continuous ambulatory peritoneal dialysis.
Ng YY; Lee SD; Wu SC; Liu WT; Chia WL; Huang TP
Perit Dial Int; 1993; 13(2):132-5. PubMed ID: 7684259
[TBL] [Abstract][Full Text] [Related]
2. Antibodies to hepatitis C virus in uremic patients on continuous ambulatory peritoneal dialysis.
Ng YY; Lee SD; Wu SC; Yang WC; Chiang SS; Huang TP
J Med Virol; 1991 Dec; 35(4):263-6. PubMed ID: 1724984
[TBL] [Abstract][Full Text] [Related]
3. The prevalence of hepatitis C virus antibodies in patients treated with continuous ambulatory peritoneal dialysis.
Huang CC; Wu MS; Lin DY; Liaw YF
Perit Dial Int; 1992; 12(1):31-3. PubMed ID: 1311963
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of hepatitis C virus antibody between hemodialysis and continuous ambulatory peritoneal dialysis patients.
Lee HY; Kang DH; Park CS; Kim KY; Kang SW; Kim HS; Choi KH; Ha SK; Han DS
Yonsei Med J; 1993 Dec; 34(4):371-80. PubMed ID: 7510444
[TBL] [Abstract][Full Text] [Related]
5. Environmental transmission of hepatitis B and hepatitis C viruses within the hemodialysis unit.
Cendoroglo Neto M; Manzano SI; Canziani ME; Silva AE; Cirenza LF; Sesso Rde C; Ajzen H; Draibe SA
Artif Organs; 1995 Mar; 19(3):251-5. PubMed ID: 7539998
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C infection among dialysis patients: a comparison between patients on maintenance haemodialysis and continuous ambulatory peritoneal dialysis.
Chan TM; Lok AS; Cheng IK
Nephrol Dial Transplant; 1991; 6(12):944-7. PubMed ID: 1724691
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of antibodies to hepatitis C virus in patients on peritoneal dialysis--a multicenter study.
Gladziwa U; Schlipköter U; Lorbeer B; Cholmakow K; Roggendorf M; Sieberth HG
Clin Nephrol; 1993 Jul; 40(1):46-52. PubMed ID: 7689431
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of hepatitis C antibodies (HCV) in a dialysis population at one center.
Selgas R; Martinez-Zapico R; Bajo MA; Romero JR; Munoz J; Rinon C; Miranda B; Miguel JL
Perit Dial Int; 1992; 12(1):28-30. PubMed ID: 1311962
[TBL] [Abstract][Full Text] [Related]
9. Incidence of antibodies to hepatitis C virus in patients undergoing chronic dialysis and CAPD.
Nakashima F; Sata M; Tokeshi S; Nakano H; Nakashima M; Nakashima N; Motomura K; Motomura S; Ide M; Tanikawa K
Kurume Med J; 1993; 40(4):249-53. PubMed ID: 7516454
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C antibodies in patients on peritoneal dialysis: prevalence and risk factors.
Lee GS; Roy DK; Fan FY; Thanaletchumi K; Woo KT
Perit Dial Int; 1996; 16 Suppl 1():S424-8. PubMed ID: 8728237
[TBL] [Abstract][Full Text] [Related]
11. Comparison of three different tests for assessment of hepatitis C virus in dialysis patients.
Castelnovo C; Lunghi G; De Vecchi A; Grancini A; Como G; Graziani G; Scalamogna A; Ponticelli C
Perit Dial Int; 1995; 15(6):241-5. PubMed ID: 7578501
[TBL] [Abstract][Full Text] [Related]
12. Increased prevalence of HCV antibodies in dialyzed Ashkenazi Jews--a possible ethnic predisposition.
Golan E; Korzets Z; Cristal-Lilov A; Ben-Tovim T; Bernheim J
Nephrol Dial Transplant; 1996 Apr; 11(4):684-6. PubMed ID: 8671859
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of antihepatitis C antibodies in patients treated with continuous ambulatory peritoneal dialysis and hemodialysis.
Pérez-Fontán M; Moncalián J; Rodríguez-Carmona A; Arrojo F
Nephron; 1991; 58(3):381-2. PubMed ID: 1654529
[No Abstract] [Full Text] [Related]
14. Prevalence of antibodies against hepatitis C virus in a dialysis unit.
Cantù P; Mangano S; Masini M; Limido A; Crovetti G; DeFilippo C
Nephron; 1992; 61(3):337-8. PubMed ID: 1323784
[TBL] [Abstract][Full Text] [Related]
15. A comparison between one first generation and three second generation anti-HCV ELISAs: an investigation in high- and low-risk subjects in correlation with recombinant immunoblot assay and polymerase chain reaction.
Bååth L; Widell A; Nordenfelt E
J Virol Methods; 1992 Dec; 40(3):287-96. PubMed ID: 1282130
[TBL] [Abstract][Full Text] [Related]
16. Evidence against transmission of hepatitis C virus through hemodialysis ultrafiltrate and peritoneal fluid.
Caramelo C; Navas S; Alberola ML; Bermejillo T; Reyero A; Carreño V
Nephron; 1994; 66(4):470-3. PubMed ID: 7517019
[TBL] [Abstract][Full Text] [Related]
17. [Infection of hepatitis C virus in patients with chronic renal failure undergoing hemodialysis therapy and staff members].
Miyasaka M
Nihon Jinzo Gakkai Shi; 1991 Oct; 33(10):989-99. PubMed ID: 1722830
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of hepatitis C virus infection in hemodialysis patients: a longitudinal study comparing the results of RNA and antibody assays.
Chan TM; Lok AS; Cheng IK; Chan RT
Hepatology; 1993 Jan; 17(1):5-8. PubMed ID: 7678575
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of antibody to hepatitis C virus in hemodialysis patients.
Hayashi J; Nakashima K; Kajiyama W; Noguchi A; Morofuji M; Maeda Y; Kashiwagi S
Am J Epidemiol; 1991 Sep; 134(6):651-7. PubMed ID: 1659184
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and risk factors for hepatitis C virus infection in continuous ambulatory peritoneal dialysis patients.
Górriz JL; Miguel A; García-Ramón R; Pérez-Contreras J; Olivares J; Gómez-Roldán C; Alvariño J; Lanuza M
Nephrol Dial Transplant; 1996 Jun; 11(6):1109-12. PubMed ID: 8671977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
